十齿草次碱 | 10183-64-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 大环内酯类和类似物
• 中文名称: 十齿草次碱
• 英文名称: (±)-decinine
• 英文别名: decinine；2'-hydroxy-4'',5''-dimethoxy-13,14-dihydro-lythran-12-one；([1,2]R_a,3²S)-1⁶-hydroxy-2^4,5-dimethoxy-(3²rH,3⁴tH,3^9at)-3-octahydro-4-oxa-1(1,3),2(1,2)-dibenzena-3(4,2)-quinolizina-cycloheptaphan-5-one；(+/-)-Decinin；Lythridin；Decimin；(1S,17S,19S)-9-hydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.18,12.02,7.019,24]hexacosa-2,4,6,8,10,12(26)-hexaen-15-one
• CAS: 10183-64-9；17349-05-2；57550-21-7
• 化学式: C₂₆H₃₁NO₅
• 分子量: 437.536
• InChiKey: CUPVWBKZXUQNOL-SPEDKVCISA-N

物化性质

• 沸点：
  653.8±55.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  32
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  68.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  十齿草次碱 生成 4'',5''-dimethoxy-5-methyl-13,14-dihydro-4,5-seco-lythran-2'-ol
  参考文献：
  名称：

  千屈菜生物碱。七。Decodon和Hemia的联苯生物碱的结构和立体化学。

  摘要：

  DOI：

  10.1021/ja00741a021
• 作为产物：
  描述：

  4-羟基肉桂酸甲酯 在 4-二甲氨基吡啶 、 oxovanadium(V) fluoride 、 palladium on carbon 、 20 % Pd(OH)2/C 、 氢气 、 potassium carbonate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三氟乙酸 、 potassium iodide 、 sodium hydroxide 作用下， 以 乙醇 、 二氯甲烷 、 乙酸乙酯 、 丙酮 为溶剂， 反应 39.0h， 生成 十齿草次碱
  参考文献：
  名称：

  Total Synthesis of (±)-Decinine via an Oxidative Biaryl Coupling with Defined Axial Chirality

  摘要：

  The total synthesis of (+/-)-decinine has been achieved. The key steps in the synthesis involved the formation of lasubine II via a gold catalyzed annulation of 1-(but-3-yn-1-yl)piperidine and the formation of the 12-membered ring of decinine (1) with complementary atropselectivity via a VOF3-mediated oxidative biaryl coupling reaction.

  DOI：

  10.1021/ol3015573

文献信息

• Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
  申请人：Nyce W. Jonathan

  公开号：US20050070487A1

  公开（公告）日：2005-03-31

  A pharmaceutical or veterinary composition, comprises a first active agent selected from a non-glucocorticoid steroid or analogues, a ubiquinone, or salts thereof, and a second active agent comprising a bronchodilator. The composition is provided in various formulations and in the form of a kit The products of this patent are applied to the prophylaxis and treatment of respiratory, lung and malignant diseases.

  一种药物或兽药组合物，包括选自非糖皮质激素类固醇或类似物、泛酰酮或其盐类的第一种活性剂，以及由支气管扩张剂组成的第二种活性剂。本专利产品可用于预防和治疗呼吸系统疾病、肺部疾病和恶性疾病。
• COMBINATION OF ANTI-MUSCARINIC AGENTS AND NON-GLUCOCORTICOID STEROIDS
  申请人：Epigenesis Pharmaceuticals, Inc.

  公开号：EP1511500A2

  公开（公告）日：2005-03-09
• EP1511500A4
  申请人：——

  公开号：EP1511500A4

  公开（公告）日：2009-04-29
• Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
  申请人：——

  公开号：US20030216329A1

  公开（公告）日：2003-11-20

  A pharmaceutical or veterinary composition comprises a non-corticosteroids, and/or salts thereof, and an anti-muscarinic (anti-cholinergic) agent, and\or pharmaceutically or veterinarilly acceptable salts thereof. The composition is provided in various formulations and in the form of a kit. The products of this patent are useful in the prophylaxis and treatment of various respiratory, lung and malignant diseases.
• COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT
  申请人：Nyce Jonathan W.

  公开号：US20090258046A1

  公开（公告）日：2009-10-15

  A pharmaceutical or veterinary composition, which comprises a first active agent selected from a non-glucocorticoid steroid or analogues, a ubiquinone, or salts thereof, and a second active agent comprising a bronchodilator. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of respiratory, lung and malignant diseases.